Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 09-2015 | 09-2014 | 09-2013 | |
| Sales | 11,364 | 0 | 0 | 0 | 0 |
| Gross Profit | 11,364 | N/A | N/A | N/A | N/A |
| Operating Expenses | 23,658 | 13,971 | 19,767 | 19,261 | 20,593 |
| Operating Income | -12,294 | -13,971 | -19,767 | -19,261 | -20,593 |
| Other Income | -3,994 | 268 | 1,059 | 5,156 | 1,273 |
| Pre-tax Income | -16,288 | -13,703 | -18,708 | -14,105 | -19,320 |
| Income Tax | 62 | 52 | 29 | 26 | 15 |
| Net Income Continuous | -16,350 | -13,755 | -18,737 | -14,131 | -19,335 |
| Net Income | $-16,350 | $-13,755 | $-18,737 | $-14,131 | $-19,335 |
| EPS Basic Total Ops | -13.19 | -6.45 | -13.70 | -19.82 | -37.24 |
| EPS Basic Continuous Ops | -13.19 | -6.45 | -13.71 | -19.83 | -37.10 |
| EPS Diluted Total Ops | -13.19 | -6.45 | -13.70 | -19.82 | -37.24 |
| EPS Diluted Continuous Ops | -13.19 | -6.45 | -13.71 | -19.83 | -37.10 |
| EPS Diluted Before Non-Recurring Items | -13.16 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-11,215 | $-13,890 | $-19,570 | $-18,658 | $-19,952 |